Valneva SE (VALN) Operating Margin (2021 - 2026)

Valneva SE's (VALN) quarterly Operating Margin came in at 90.84% in Q1 2026, down 1096.0% year-on-year from 9.12% in Q1 2025, and up 116.7% quarter-over-quarter from 544.02% in Q4 2025.

Valneva SE (VALN) Operating Margin (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Operating Margin across 6 years of filings, most recently posting 90.84% for Q1 2026.

  • Operating Margin for Q1 2026 came in at 90.84%, down 1096.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 68.04% (down 4829.0% YoY), and the FY2025 annual result was 51.97%, down 6013.0% from the prior year.
  • Operating Margin came in at 90.84% for Q1 2026 at Valneva SE, up from 544.02% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 227.13% in Q3 2022 to a low of 768.58% in Q2 2022.
  • The 5-year median for Operating Margin is 90.84% (2026), against an average of 70.81%.
  • Peak annual rise in Operating Margin reached 133190 bps in 2022, while the deepest fall reached 114563 bps in 2022.
  • Valneva SE's Operating Margin stood at 139.56% in 2022, then slumped by 129 bps to 319.99% in 2023, then dropped by 7 bps to 343.4% in 2024, then sank by 58 bps to 544.02% in 2025, then soared by 117 bps to 90.84% in 2026.
  • The last three Operating Margin figures came in at 90.84% (Q1 2026), 544.02% (Q4 2025), and 148.88% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 38.10%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 90.84%

Historic Data

Download Data
DateValue
Mar 31, 2026 90.84%
Dec 31, 2025 -544.02%
Sep 30, 2025 148.88%
Jun 30, 2025 108.11%
Mar 31, 2025 101.80%
Dec 31, 2024 -343.40%
Sep 30, 2024 106.59%
Jun 30, 2024 114.41%
Mar 31, 2024 108.21%
Dec 31, 2023 -319.99%
Sep 30, 2023 120.39%
Jun 30, 2023 -48.96%
Mar 31, 2023 -51.63%
Dec 31, 2022 -139.56%
Sep 30, 2022 227.13%
Jun 30, 2022 -768.58%
Mar 31, 2022 -113.98%
Dec 31, 2021 1,006.07%
Sep 30, 2021 -1,104.77%
Jun 30, 2021 -351.92%